Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Key Driver Transforming the Calcitonin Salmon Market in 2025
    Key Driver Transforming the Calcitonin Salmon Market in 2025 Business
  • Dolman Law Group Currently Accepting Hair Relaxer-Uterine Cancer Cases
    Dolman Law Group Currently Accepting Hair Relaxer-Uterine Cancer Cases Business
  • Author Tom Pisello Releases New Book “Growth Through Grief” to Empower Widowers on Their Journey to Healing
    Author Tom Pisello Releases New Book “Growth Through Grief” to Empower Widowers on Their Journey to Healing World News
  • Global General Freight Trucking Market on an Upward Trajectory
    Global General Freight Trucking Market on an Upward Trajectory World News
  • Hotels in Fredericksburg Texas Staying at High Occupancy
    Hotels in Fredericksburg Texas Staying at High Occupancy Business
  • Senior Official for Global Women’s Issues Kat Fotovat Travels to Bangladesh
    Senior Official for Global Women’s Issues Kat Fotovat Travels to Bangladesh World News
  • Crypto Exchange BTSE to Apply for Hong Kong Digital Asset Licenses
    Crypto Exchange BTSE to Apply for Hong Kong Digital Asset Licenses Business
  • War Day 240: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin
    War Day 240: war diaries w/Advisor to Ukraine President, Intel Officer @Alexey Arestovych & #Feygin World News
Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Posted on November 15, 2024 By NewsEditor

Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Solaris Endovascular Inc

Solaris SX is very flexible

Solaris SX Flexibility

NEW ORLEANS, LA, UNITED STATES, November 13, 2024 /EINPresswire.com/ — Solaris Endovascular, Inc. Launching to Address Vascular Health Challenges Globally

Solaris Endovascular, Inc. proudly announces its formation to develop solutions for Dialysis Access and Peripheral Artery Disease (PAD). Solaris Endovascular develops evidence-based technologies, intended to treat and extend the patency of dialysis access fistulae, grafts, and peripheral arteries to allow patients to lead healthier lives with fewer interventions.

End-Stage Kidney Disease (ESKD) is a major health concern affecting approximately 10 million people worldwide with approximately 3 million people receiving kidney replacement therapy and relying on hemodialysis to survive. Over 50% of these patients experience vascular access failures within the first year and are subjected to hospital admissions and repeated costly endovascular or surgical interventions to restore their lifeline to dialysis—this drastically impacts quality of life, treatment effectiveness and survival.

In April 2024, the American Heart Association reported that the global prevalence of peripheral artery disease (PAD) may be as high as 230 million people. PAD can progress from painful walking to critical limb ischemia, and many patients require revascularization procedures to restore blood flow, improve symptoms, or prevent amputations.

Stent-grafts are emerging as the preferred minimally invasive treatment for these conditions and Solaris Endovascular is currently selling the latest generation of stent-grafts. The flagship Solaris(TM) SX Vascular Stent Graft employs the most advanced electrospinning PTFE impermeable membrane that prevents tissue ingrowth, maximizes patency, and reduces restenosis. This thin, multi-directional PTFE membrane encapsulates a nitinol stent that provides flexibility, high radial strength, and crush resistance for optimal blood flow. These features are already proven in global markets with more than 13,000 units sold to date. Interventional and endovascular physicians worldwide have chosen Solaris SX for its trackability and precise pinpoint deployment, ensuring accurate placement.

“Bringing this innovative technology to the United States is a major step forward in improving the lives of patients,” said Dr. Marco Costa, Chairman and Chief Medical & Scientific Officer at Solaris Endovascular Inc. “Solaris Endovascular’s advanced covered stent platforms will not only reduce the burden of repeated interventions but will also dramatically enhance the quality of life and life expectancy for those who suffer from these debilitating conditions.”

Looking ahead, Solaris Endovascular is already enrolling patients in clinical trials for the first of its kind Solaris(TM) DE Drug-Eluting Vascular Stent Graft – that will address the remaining unmet need in covered stents: edge stenosis. Solaris DE incorporates Sirolimus, a powerful and safe anti-proliferative agent that revolutionized the treatment of coronary artery disease with the virtual elimination of restenosis, from 30% to 3%.

“We expect Solaris DE to deliver similar transformative results to patients with ESKD and PAD,” said Dr. Costa.

CEO Randy Hubbell emphasized the company’s unique position in the market: “Solaris Endovascular represents a rare opportunity to start a new company that is revenue producing from the beginning, has a decade-plus manufacturing expertise in stents, stent grafts and endovascular drug delivery, and a proven product supported by clinical studies in multiple markets before entering the U.S. Our platform addresses a significant unmet need in both dialysis access and PAD, offering life-changing solutions for patients while setting a new standard in endovascular care.”

As Solaris Endovascular prepares for the U.S. registration process, it is committed to driving meaningful improvements in patient outcomes, reducing hospital readmissions, and lowering overall healthcare costs.

About Solaris Endovascular, Inc.

Solaris Endovascular, Inc. is a growth stage US-based medical device company developing advanced endovascular solutions for patients suffering from dialysis access challenges and Peripheral Artery Disease. With a proven stent platform and innovative drug-eluting technology, led by seasoned executives with extensive experience in cardiovascular MedTech, Solaris Endovascular is uniquely positioned and committed to improving long-term patient outcomes and transforming vascular health.

For more information, please visit: [www.solarisendovascular.com]

Randy Hubbell
Solaris Endovascular, Inc.
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

You just read:

News Provided By

November 13, 2024, 13:30 GMT

Distribution channels:
Agriculture, Farming & Forestry Industry, Banking, Finance & Investment Industry, Beauty & Hair Care, Business & Economy, Chemical Industry, Companies, Conferences & Trade Fairs, Culture, Society & Lifestyle, Education, Emergency Services …


EIN Presswire’s priority is author transparency. We do our best to weed out false and misleading content. The content above is
the sole responsibility of the author who makes it available. If you have any complaints, kindly contact the author above.

Article originally published on www.einpresswire.com as Solaris Endovascular, Inc. Launches to Revolutionize Vascular Health Solutions Globally

Business

Post navigation

Previous Post: Maria Cecilia Conder selected as Top Board Member of the Year in Fine Arts by IAOTP
Next Post: Tech and Social Impact Leaders Converge at Goodera’s AI for Impact Summit

Related Posts

  • Little Saint Nick Foundation Celebrates Milestone Partnership with Shriner’s Children’s Hospital
    Little Saint Nick Foundation Celebrates Milestone Partnership with Shriner’s Children’s Hospital Business
  • Peace and Cooperation Unites Global Leaders to Champion Moral Leadership and Peacebuilding
    Peace and Cooperation Unites Global Leaders to Champion Moral Leadership and Peacebuilding Business
  • PHP/IOP Behavioral Health Reacts to Maryland Teen Suffering in Waiting Room for 76 Days; Provides Critical Solution to Ongoing Crisis
    PHP/IOP Behavioral Health Reacts to Maryland Teen Suffering in Waiting Room for 76 Days; Provides Critical Solution to Ongoing Crisis Business
  • Population Health Management Market Size, Share, Revenue, Trends And Drivers For 2023-2032
    Population Health Management Market Size, Share, Revenue, Trends And Drivers For 2023-2032 Business
  • Crypto Rises to Highest in a Month as Fed Cut Bets Stall
    Crypto Rises to Highest in a Month as Fed Cut Bets Stall Business
  • Indian Gin Market Drivers Shaping Future Growth, Revenue USD 1,598.2 Million by 2030
    Indian Gin Market Drivers Shaping Future Growth, Revenue USD 1,598.2 Million by 2030 Business
October 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
« Sep    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • Unveiling Growth Developments with Latest UpdatesOctober 11, 2025
  • Citigroup’s $16M Charlotte Expansion and What It Means for Fintech TalentOctober 10, 2025
  • France, Overseas France, and French Speaking Africa Airport Baggage Handling System Market by 2031October 10, 2025
  • Scheduled maintenanceOctober 10, 2025
  • The Global Games Show 2025, hosted by VAP Group with Abu Dhabi Convention & Exhibition Bureau, Returns for 3rd EditionOctober 9, 2025
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • My goal is for every person to be able to smile quickly
    My goal is for every person to be able to smile quickly Business
  • Global ECommerce Market Is Projected To Grow At A 11% Rate Through The Forecast Period
    Global ECommerce Market Is Projected To Grow At A 11% Rate Through The Forecast Period World News
  • Import Invoices and Payee Lists instantly with the Integration of OnlineCheckWriter.com and Sage Intacct
    Import Invoices and Payee Lists instantly with the Integration of OnlineCheckWriter.com and Sage Intacct World News
  • Expected to Grow at a CAGR of 5.8% from 2018 to 2025 , Claims AMR
    Expected to Grow at a CAGR of 5.8% from 2018 to 2025 , Claims AMR Business
  • Fitness Platforms For Disabled Market Size, Share, Revenue, Trends And Drivers For 2023-2032
    Fitness Platforms For Disabled Market Size, Share, Revenue, Trends And Drivers For 2023-2032 World News
  • Secretary Blinken’s Meeting with Cessation of Hostilities Agreement (COHA) Signatories
    Secretary Blinken’s Meeting with Cessation of Hostilities Agreement (COHA) Signatories World News
  • Secretary Blinken’s Meeting with Cessation of Hostilities Agreement (COHA) Signatories
    Deputy Secretary Sherman’s Meeting with Chief of Staff for Navalny, Leonid Volkov World News
  • War Day 160: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych  & #Feygin
    War Day 160: war diaries w/Advisor to Ukraine President, Intel Officer @arestovych & #Feygin World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2023 195 News. All Rights Reserved by Coolaser | Partner of VUGA Enterprises |  Advertising: Get Published

Powered by .